SOLICITATION NOTICE
B -- Drug Data Report - Package #1 - Package #2
- Notice Date
- 4/18/2012
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- U.S. Government Accountability Office, Acquisition Sourcing Management, Acquisition Management, 441 G Street, NW, Washington, District of Columbia, 20548
- ZIP Code
- 20548
- Solicitation Number
- GAO-12-N-0026
- Point of Contact
- Larry J. Gooding, Phone: 202-512-3871, Carmencita D. Jones, Phone: 202-512-6475
- E-Mail Address
-
goodingl@gao.gov, jonescd@gao.gov
(goodingl@gao.gov, jonescd@gao.gov)
- Small Business Set-Aside
- N/A
- Description
- Drug Data Solicitation SF 1449 SF 1449 Executive Summary This is a combined synopsis solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Proposals are being requested and a written solicitation will not be issued. GAO anticipates awarding a fixed price contract. This combined synopsis/solicitation is organized into eight parts: (1) Requirements; (2) Applicability of FAR Provisions; (3) Proposals; (4) Technical Evaluation and Award; (5) Late Clause; (6) Point of Contact; (7) Attachment: A- Drug Data List. (8) Clauses Background Certain drugs, such as chemotherapy drugs, administered primarily in a physician’s office, hospital outpatient clinic, or other outpatient setting, are covered through Medicare Part B. Nearly one-third of these drugs are for the treatment of cancer or its side effects. Others are for the treatment of end-stage renal disease, asthma, Crohn’s disease, and additional diseases and conditions. Several are vaccines. Congress has asked GAO to study the Part B drugs and, for each of the 55 drugs, estimate the proportion of calendar year 2010 national expenditures and utilization that is associated with Medicare beneficiaries. Objectives The contractor shall provide GAO with a calendar year 2010 national expenditure and utilization estimate for each of the 55 drugs listed on Attachment A. The estimates will be included in the GAO report described above and will be used as a denominator to estimate the proportion of national expenditures and utilization associated with Medicare beneficiaries. See Attachments: SF 1449 Executive Summary Solicitation
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/GAO/GAOAM/GAOAM1/GAO-12-N-0026/listing.html)
- Record
- SN02724802-W 20120420/120418234742-f42988ddc3fd2d260cdae2937f7c6b87 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |